Here we evaluated all four validated biomarkers on these new transcriptomic studies and found PAX7 target gene repression to be the most robust in discriminating FSHD from control on single-cell RNA-Seq data, while all four biomarkers were equivalent on MRI-guided muscle biopsies. Here, PAX7 is linked to facioscapulohumeral muscular dystrophy.